KRM Ayurveda IPO
KRM Ayurveda IPO Listing Day Performance
KRM Ayurveda listed on NSE SME on 29 January 2026 at ₹180.70, a 33.85% premium over the issue price of ₹135. A retail investor allotted the minimum application of 2,000 shares (2 lots) gained ₹91,400 at the listing price.
GMP vs actual listing
| Last GMP before listing | ₹45 (+33.3%) |
| GMP-implied listing | ₹180 |
| Actual listing | ₹180.70 |
| Difference | +₹0.7 (+0.4%) |
Demand going into listing
| Subscribed overall | 74.43× |
| QIB | 63.31× |
| NII | 136.1× |
| Retail | 54.21× |
Market Sentiment
IPO Details
Market Lot Size
IPO Reservation
Financial Analysis
Financial Data
Financial Performance
| Metric | 2023 | 2024 | 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 89.38 | 67.57 | 76.95 | 48.65 |
| Expense | 79.29 | 62.85 | 60.61 | 37.65 |
| Profit (PAT) | 7.60 | 3.41 | 12.10 | 8.14 |
| Total Assets | 39.48 | 43.91 | 66.79 | 78.12 |
Peer Comparison
| Company | EPS | P/E | Market Cap (Cr) |
|---|---|---|---|
| Jeena Sikho Lifecare Ltd. | 8.86 | 76.58 | 31 |
| Vaidya Sane Ayurved Laboratories Ltd | 3.07 | 93.20 | 5 |
Promoters & Holding Pattern
Promoters: Mr. Puneet Dhawan and Mrs. Tanya Dhawan
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 1,55,20,800 | 92.16% |
| Promoter Holding Post Issue | 2,12,60,800 | 67.28% |
Strengths & Risks
- Strongly subscribed — 74.4x overall (final).
- Strong institutional (QIB) demand — 63.3x.
- Solid profit margin — 15.7%.
- Strong return on equity — 68%.
- Elevated leverage — debt/equity of 1.31.
- Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.
From this issue's live data. Not investment advice — read the RHP.
Company Information
KRM Ayurveda at a glance
From the company's description: “KRM Ayurveda Ltd started its journey on 3 September 2019, with the work of manufacturing Ayurvedic products, herbal and botanical remedies, medicines, supplements, and possibly skin care / wellness-related items.”
KRM Ayurveda is raising ₹77.49 crore through an IPO on the NSE Emerge (SME) in the Ayurveda & Healthcare sector. All of it is a fresh issue: there is no offer for sale, so every rupee raised goes to the company rather than to selling shareholders. Main stated uses of the fresh money: Working Capital Requirement (₹18 crore), Capital Expenditure for Construction and Development of Telemedicine Operational Facilities (₹13.67 crore) and Repayment/Prepayment of loan (₹12.5 crore).
Revenue went from ₹89.38 crore in 2023 to ₹76.95 crore in 2025, down 14% over 2 years. Profit after tax went from ₹7.6 crore to ₹12.1 crore, a net margin of 16% in the latest year.
The promoter, Mr. Puneet Dhawan and Mrs. Tanya Dhawan, holds 92% before the issue and 67% after it — a dilution of 24.9 percentage points. Debt stands at 1.31 times equity.
Written from the issue's offer-document figures shown on this page. Not investment advice.
Company Contact Information
KRM Ayurveda Ltd., A-16, G T Karnal road, North West Delhi, New Delhi, 110033
Objects of the Issue
| Purpose | Amount (Cr) |
|---|---|
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | 13.67 |
| Purchase of CRM Software and Hardware Infrastructure | 1.42 |
| Human Resources | 5.44 |
| Repayment/Prepayment of loan | 12.50 |
| Working Capital Requirement | 18.00 |
| General Corporate Purpose | - |
Resources & Documents
Anchor Investors
IPO Documents
Draft Red Herring ProspectusKRM Ayurveda IPO - Quick Take
KRM Ayurveda has set a price band of Rs 129–Rs 135 per share for an issue size of Rs 77 crore in the ayurveda & healthcare sector. The stock listed with a 33.85% gain versus its issue price on January 29, 2026.
The company operates in the ayurveda & healthcare space.
The issue is promoted by Mr. Puneet Dhawan and Mrs. Tanya Dhawan with NEXGEN Financial Solutions Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards capital Expenditure for Construction and Development of Telemedicine Operational Facilities (Rs 14 crore) and purchase of CRM Software and Hardware Infrastructure (Rs 1 crore).
On fundamentals, the company is posting revenue growth of 13.9%, a profit margin of 15.7%, return on equity of 67.9% in its most recent reported period. Listed peers in this segment include Jeena Sikho Lifecare Ltd. (P/E 76.58x, market cap Rs 31 crore) and Vaidya Sane Ayurved Laboratories Ltd (P/E 93.20x, market cap Rs 5 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
KRM Ayurveda IPO: Lead Manager & Registrar Track Record
How the firm running this issue and its registrar have fared on the other IPOs we track. Each firm's figures leave out KRM Ayurveda itself, so they describe what came before it.
- KRM Ayurveda listed at +33.9% on day one; the median of 193 listings was +1.5% (better than 82% of them).
- Subscribed 74.43x against a median of 3.98x across 192 issues (higher than 74%).
- Average listing-day move across all 194 SME listings we track: +11.6%.
| Firm | Other IPOs | Listed at / above issue | Avg move | Median |
|---|---|---|---|---|
| NEXGEN Financial Solutions Pvt. Ltd. Lead manager | 5 0 MB · 5 SME | 60% 3 of 5 | +15.8% | +2.9% |
| Skyline Financial Services Pvt. Ltd. Registrar | 16 0 MB · 16 SME | 69% 11 of 16 | Check allotment → | |
Recent listings managed by NEXGEN Financial Solutions Pvt. Ltd. (5)
Best: IC Electricals +67.7% · Weakest: Manilam Industries −20%
| IPO | Listed | Listing-day move |
|---|---|---|
| Shakti Polytarp | 22 Sep 2026 | −0.2% |
| Optimystix Entertainment | 14 Aug 2026 | +2.9% |
| IC Electricals | 10 Jul 2026 | +67.7% |
| Manilam Industries | 27 Feb 2026 | −20% |
| Defrail Technologies | 19 Jan 2026 | +28.4% |
A SEBI-registered merchant banker that runs the issue: due diligence, drafting the offer document, setting the price band with the company, and marketing the IPO to investors.
Finalises the basis of allotment, credits shares to demat accounts, releases blocked funds for unsuccessful bids and handles investor queries about the issue.
Listing-day move = exchange opening price vs issue price (band ceiling where the final price isn't recorded). Counts cover IPOs we track only. Past listings don't predict this one; this is not investment advice.
Frequently Asked Questions
KRM Ayurveda IPO GMP — What It Means
Its last GMP before listing was 33.3%. Of the 34 SME IPOs we have tracked with a final GMP of 25% or more, 34 listed above, 0 flat and 0 below the issue price; KRM Ayurveda listed 33.9% above its issue price.
See the full KRM Ayurveda GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
Same sector or same stage as KRM AyurvedaNo comments yet. Be the first to share your opinion!